Squarepoint’s AbCellera Biologics ABCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$111K Sell
31,749
-101,320
-76% -$365K ﹤0.01% 4048
2025
Q4
$455K Buy
133,069
+30,598
+30% +$137K ﹤0.01% 3287
2025
Q3
$515K Buy
102,471
+88,152
+616% +$388K ﹤0.01% 3207
2025
Q2
$49.1K Sell
14,319
-4,431
-24% -$11K ﹤0.01% 4308
2025
Q1
$41.8K Sell
18,750
-38,935
-67% -$112K ﹤0.01% 4371
2024
Q4
$169K Buy
57,685
+44,367
+333% +$124K ﹤0.01% 4537
2024
Q3
$34.6K Sell
13,318
-55,590
-81% -$154K ﹤0.01% 3998
2024
Q2
$204K Buy
68,908
+22,132
+47% +$83.7K ﹤0.01% 3652
2024
Q1
$212K Sell
46,776
-5,231
-10% -$26.7K ﹤0.01% 3585
2023
Q4
$297K Buy
52,007
+247
+0.5% +$1.15K ﹤0.01% 3365
2023
Q3
$238K Sell
51,760
-72,628
-58% -$442K ﹤0.01% 3311
2023
Q2
$804K Sell
124,388
-34,039
-21% -$232K ﹤0.01% 2328
2023
Q1
$1.19M Sell
158,427
-39,145
-20% -$355K ﹤0.01% 1775
2022
Q4
$2M Buy
197,572
+148,779
+305% +$1.72M 0.01% 1364
2022
Q3
$483K Sell
48,793
-75,570
-61% -$829K ﹤0.01% 2218
2022
Q2
$1.32M Sell
124,363
-62,446
-33% -$529K 0.01% 1428
2022
Q1
$1.82M Buy
186,809
+106,528
+133% +$1.01M 0.01% 1209
2021
Q4
$1.15M Buy
80,281
+23,746
+42% +$360K ﹤0.01% 1608
2021
Q3
$1.13M Buy
56,535
+33,191
+142% +$587K ﹤0.01% 1500
2021
Q2
$514K Buy
23,344
+7,683
+49% +$212K ﹤0.01% 2110
2021
Q1
$532K Buy
+15,661
New +$624K ﹤0.01% 1969

Other funds holding ABCL